Medical Testing

Early indicators hint at US COVID-19 uptick CIDRAP

Though COVID has held at very low levels late spring and into summer, some early indicators show signs of rising activity, according to the latest data from the Centers for Disease Control and Prevention (CDC).

In other developments, the CDC and the Department of Health and Human Services (HHS) fleshed out more details about when the updated COVID-19 vaccine will roll out and how federal health officials will ensure that uninsured and underinsured people can receive their doses.

...

Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021–June 2022 Predicting COVID-19 Using Wastewater Surveillance Emerging Infectious Diseases journal

Analysis of wastewater is used in many settings for surveillance of SARS-CoV-2, but it remains unclear how well wastewater testing results reflect incidence. Denmark has had an extensive wastewater analysis system that conducts 3 weekly tests in ≈200 sites and has 85% population coverage; the country also offers free SARS-CoV-2 PCR tests to all residents. Using time series analysis for modeling, we found that wastewater data, combined with information on circulating variants and the number of human tests performed, closely fitted the incidence curve of persons testing positive

All-species COVID-19 test can track disease in wild, domesticated animals - UPI.com Researchers can now detect the COVID-19 virus in any animal using a new all-species test. UPI

...

It's an advance that they say will help track COVID-19 variants in wild and domesticated animals.

..

Moderna seeks regulatory approval of RSV vaccine for people 60 and older - UPI.com Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States, European Union, Switzerland and Australia. UPI

...

Moderna said the regulatory applications come after positive data from a study of approximately 37,000 adults 60 or older in 22 countries. Its vaccine to protect from respiratory syncytial virus was found in these trials to be 83.7% effective as defined by two or more symptoms.

...